Lithium versus carbamazepine in the maintenance treatment of bipolar disorders - A randomised study

Journal of Affective Disorders

Volumn 43, Issue 2, 1997, Pages 151-161

  Greil, W ^a   Ludwig Mayerhofer, W ^a   Erazo, N ^a   Schochlin C ^a   Schmidt, S ^a   Engel, R R ^a   Czernik, A ^b   Giedke, H ^c   Muller Oerlinghausen B ^d   Osterheider, M ^e   Rudolf, G A E ^f   Sauer, H ^g   Tegeler, J ^h   Wetterling, T ⁱ  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

^e UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h HEINRICH HEINE UNIVERSITY   (Germany)

ⁱ UNIVERSITY OF LÜBECK   (Germany)

Author keywords

bipolar disorder; carbamazepine; lithium carbonate; randomised controlled trial; recurrence; treatment outcome

Indexed keywords

CARBAMAZEPINE; LITHIUM;

ADULT; ARTICLE; BIPOLAR DEPRESSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CARBAMAZEPINE; FEMALE; HUMANS; LITHIUM CARBONATE; MALE;

EID: 17544403029     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(96)01427-9     Document Type: Article

References (41)

1. Aitken, R.C.B. (1969) Measurement of feelings using visual analogue scales. Proc. Roy. Soc. Med. 62, 989-993.
2. Angst, J. (1981) Ungelöste Probleme bei der Indikationsstellung zur Lithiumprophylaxe affektiver und schizoaffektiver Erkrankungen. Bibl. Psychiatr. 161, 34-44.
3. Bellaire, W., Demisch, K. and Stoll, K.D. (1990) Carbamazepin versus Lithium. Münch. Med. Wschr. 132 (Suppl), 82-86.
4. Breslow, N. (1970) A generalized Kruskal-Wallis test for comparing k samples subject to unequal patterns of censorship. Biometrica 57, 579-594.
5. Coppen, A., Montgomery, S.A., Gupta, R.K. and Bailey, J.E. (1976) A double-blind comparison of lithium carbonate and maprotiline in the prophylaxis of the affective disorders. Br. J. Psychiatry 128, 479-485.
6. Coxhead, N., Silverstone, T. and Cookson, J. (1992) Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder. Acta Psychiatr. Scand. 85, 114-118.
7. Dardennes, R., Even, C., Bange, F. and Heim, A. (1995) Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorder [A meta-analysis]. Br. J. Psychiatry 166, 378-381.
8. Efron, B. (1971) Forcing a sequential experiment to be balanced. Biometrica 58, 403-417.
9. Endicott, J., Spitzer, R.L., Fleiss, J.L. and Cohen, J. (1976) The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry 33, 766-771.
10. Gelenberg, A.J., Kane, J.M., Keller, M.B., Lavori, P., Rosenbaum, J.F., Cole, K. and Lavelle, J. (1989) Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. New Engl. J. Med. 321, 1489-1493.
11. Greil, W., Haag, M., Huber, D. and Schmidt, St. (1986) Maintenance treatment in affective disorders: overview and design of a collaborative study. Pharmacopsychiatry 19, 167-169.
12. Greil, W., Ludwig-Mayerhofer, W., Steller, B., Czernik, A., Giedke, H., Müller-Oerlinghausen, B., Osterheider, M., Rudolf, G.A.E., Sauer, H., Tegeler, J. and Wetterling T. (1993) The recruitment process for a multicenter study on the long-term prophylactic treatment of affective disorders. J. Affect. Disord. 28, 257-265.
13. Greil, W., Ludwig-Mayerhofer, W., Erazo, N., Engel, R.R., Czernik, A., Giedke, H., Müller-Oerlinghausen, B., Osterheider, M., Rudolf, G.A.E., Sauer, H., Tegeler, J. and Wetterling, T. (1996) Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression - a randomised study. J. Affect. Disord. 40, 179-190.
14. Greil, W., Ludwig-Mayerhofer, W., Erazo, N., Engel, R.R., Czernik, A., Giedke, H., Müller-Oerlinghausen, B., Sauer, H., Tegeler, J. and Wetterling, T. (1997) Lithium versus carbamazepine in the maintenance treatment of schizoaffective disorder - a randomised study. To Eur. Arch. Psychiatry Clin. Neurosci. 247, 42-50
15. Grof, P., Schou, M., Angst, J., Baastrup, P.C. and Weis, P. (1970) Methodological problems of prophylactic trials in recurrent affective disorders. Br. J. Psychiatry 116, 599-619.
16. Kaplan, E.L. and Meier, P. (1958) Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457-481.
17. Kupfer D.J. (1991) Long-term treatment of depression. J. Clin. Psychiatry 52 (Suppl 5), 28-34.
18. Lawless, J.F. (1992) Statistical Models and Methods for Lifetime Data. John Wiley, New York.
19. Luznat, R.M., Murphy, D.P. and Nunn, C.M.H. (1988) Carbamatepine vs Lithium in the treatment and prophylaxis of mania. Br. J. Psychiatry 153, 198-204.
20. Mantel, N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 64 156-160.
21. McElroy, S.L., Keck Jr., P.E., Pope, H.G., Hudson, J.I., Faedda, G.L. and Swann, A.C. (1992) Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am. J. Psychiatry 149, 1633-1644.
22. Montgomery, S.A. and Dunbar, G. (1993) Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression. Int. Clin. Psychopharmacol. 8, 189-195.
23. Nordic Council on Medicines (1991) Nordic drug index with classification and defined daily doses. Nordic Statistics on Medicines 1981-83. NLN Publication No.15. Uppsala.
24. Okuma, T. (1993) Effeels of carbamazepine and lithium on affective disorders. Neuropsychobiology 27, 138-145.
25. Okuma, T., Inanaga, K., Otsuki, S., Sarai, K., Takahashi, R., Hazama, H., Mori, A. and Watanabe, S. (1981) A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology 73, 95-96.
26. Oxtoby, A., Jones, A. and Robinson, M. (1989) Is your "double-blind" design truly double-blind? Br. J. Psychiatry 155, 700-701.
27. Placidi, G.F., Lenzi, A., Lazzerini, F., Cassano, G.B. and Akiskal, H.S. (1986) The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients. J. Clin. Psychiatry 47, 490-494.
28. Post, R.M., Ketter, T.A., Pazzaglia, P.J., Georges, M.S., Marangell, L. and Denicoff, K. (1993) New developments in the use of anticonvulsants as mood stabilizers. Neuropsychobiology 27, 132-137.
29. Post, R.M., Uhde, T.W., Ballenger, J.C. and Squillace, K.M. (1983) Prophylactic efficacy of carbamazepine in manic-depressive illness. Am. J. Psychiatry 140, 1602-1604.
30. Price, L.H. and Henninger, G.R. (1994) Lithium in the treatment of mood disorders. Drug Ther. 331, 591-598.
31. Simhandl, Ch., Denk, E. and Thau, K. (1993) The comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders. J. Affect. Disord. 28, 221-231.
32. Solomon, D.A., Keitner, G.I., Miller, I.W., Shea, M.T. and Keller, M.B. (1995) Course of illness and maintenance treatments for patients with bipolar disorder. J. Clin. Psychiatry 56, 5-13.
33. Spitzer, R.L., Endicott, J. and Robins, E. (1982). Forschungsdiagnosekriterien (RDC). Weinheim: Beiz. [Orig: Spitzer, R.L., Endicott, J. and Robins E. (1978) Research Diagnostic Criteria (RDC). Biometrics Research Department. New York State Psychiatric Institute, New York.]
34. Spitzer, R.L., Endicott, J. and Robins, E. (1982). Forschungsdiagnosekriterien (RDC). Weinheim: Beiz. [Orig: Spitzer, R.L., Endicott, J. and Robins E. (1978) Research Diagnostic Criteria (RDC). Biometrics Research Department. New York State Psychiatric Institute, New York.]
35. Tarone, R.E. and Ware, J. (1977) On distribution-free tests for equality of survival distributions. Biometrica 64, 156-160.
36. Thies-Flechtner, K., Müller-Oerlinghausen, B., Seibert, W., Walther, A. and Greil, W. (1996) Effect of prophylactic treatment on suicide risk in patients with major affective disorder. Pharmacopsychiatry 29, 103-107.
37. Vestergaard, P. (1992) Treatment and prevention of mania: a scandinavian perspective. Neuropsychopharmacology 7, 249-260.
38. Watkins, S.E., Callender, K., Thomas, D.R., Tidmarsh, S.F. and Shaw, D.M. (1987) The effect of carbamazepine and lithium on remission from affective illness. Br. J. Psychiatry 150, 180-182.
39. Wittchen, H.U., Zaudig, M., Schramm, E., Mombour, W., Klug, J. and Horn, R. (1987) Klinisches Interview für das DSM-III-R (SKID-P/4/87). Beiz, Weinheim. [Orig: Spitzer, R.L., Williams, J.B. and Gibbon, M. (1987) Structured Clinical Interview for DSM-III-R. Biometrics Research Department New York State Psychiatric Institute, New York.]
40. Wittchen, H.U., Zaudig, M., Schramm, E., Mombour, W., Klug, J. and Horn, R. (1987) Klinisches Interview für das DSM-III-R (SKID-P/4/87). Beiz, Weinheim. [Orig: Spitzer, R.L., Williams, J.B. and Gibbon, M. (1987) Structured Clinical Interview for DSM-III-R. Biometrics Research Department New York State Psychiatric Institute, New York.]
41. World Health Organisation (1978) Glossary and Guide to the Classification of Mental Disorders in Accordance with the Ninth Revision of the International Classification of Deseases. WHO, Geneva.